Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations

Journal of Experimental Medicine

Volumn 190, Issue 11, 1999, Pages 1697-1710

  Mackay, Fabienne ^a   Woodcock, Stephen A ^a   Lawton, Pornsri ^a   Ambrose, Christine ^a   Baetscher, Manfred ^b   Schneider, Pascal ^c   Tschopp, Jurg ^c   Browning, Jeffrey L ^a  

^a BIOGEN   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Autoantibodies; B cell; Rheumatoid factors; Transgenic; Tumor necrosis factor related

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN; RHEUMATOID FACTOR;

ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CONTROLLED STUDY; EFFECTOR CELL; IMMUNOGLOBULIN DEPOSITION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; AUTOIMMUNE DISEASES; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULINS; KIDNEY; KINETICS; LEUKOCYTE COUNT; LUNG; LYMPHATIC DISEASES; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHEUMATOID FACTOR; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033428703     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.11.1697     Document Type: Article

References (44)

1. Goodnow, C.C., J.G. Cyster, S.B. Hartley, S.E. Bell, M.P. Cooke, J.I. Healy, S. Akkaraju, J.C. Rathmell, S.L. Pogue, and K.P. Shokat. 1995. Self-tolerance check points in B cell development. Adv. Immunol. 59:279-369.
2. Miller, J.F., and A. Basten. 1996. Mechanisms of tolerance to self. Curr. Opin. Immunol. 8:815-821.
3. McDevitt, H.O., and E.K. Wakeland. 1998. Autoimmunity. Curr. Opin. Immunol. 10:647-648.
4. Rose, N.R. 1998. The role of infection in the pathogenesis of autoimmune disease. Semin. Immunol. 10:5-13.
5. Fox, D. 1997. The role of T cells in the immunopathogenesis of rheumatoid arthritis. Arthritis Rheum. 40:598-609.
6. Korganow, A.S., H. Ji, S. Mangialiao, V. Duchatelle, R. Pelanda, T. Martin, G. Degott, H. Kikutani, K. Rajewski, J.L. Pasquali, et al. 1999. From systemic T cell reactivity to organ-specific autoimmune disease via immunoglobulin. Immunity. 10:451-461.
7. Elson, C.E., R.B. Sartor, G.S. Tennyson, and R.H. Riddel. 1995. Experimental models of inflammatory bowel disease. Gastroenterology. 109:1344-1367.
8. Dohi, T., K. Fujihashi, P. Rennert, K. Iwatani, H. Kiyono, and J.R. McGhee. 1999. Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses. J. Exp. Med. 189:1169-1179.
9. Boirivant, M., I.J. Fuss, A. Chu, and W. Strober. 1998. Oxazolone colitis: a marine model of T helper cell type 2 colitis treatable with antibodies to interleukin-4. J. Exp. Med. 188: 1929-1939.
10. Rennert, P.D., J.L. Browning, R. Mebius, F. Mackay, and P.S. Hochman. 1996. Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs. J. Exp. Med. 184:1999-2006.
11. Gravestein, L.A., and J. Borst. 1998. Tumor necrosis factor receptor family members in the immune system. Semin. Immunol. 10:423-434.
12. Wang, J., and M.J. Lenardo. 1997. Molecules involved in cell death and peripheral tolerance. Curr. Opin. Immunol. 9:818-825.
13. Moulian, N., and S. Berrih-Aknin. 1998. Fas/APO-1/CD95 in health and autoimmune disease: thymic and peripheral aspects. Semin. Immunol. 10:449-456.
14. Kurts, C., F.R. Carbone, M.F. Krummel, K.M. Koch, J.F.A.P. Miller, and W.R. Heath. 1999. Signaling through CD30 protects against autoimmune diabetes mediated by CD8 T cells. Nature. 398:341-344.
15. Cope, A.P. 1998. Regulation of autoimmunity by proinflammatory cytokines. Curr. Opin. Immunol. 10:669-676.
16. Weinberg, A.D., A.T. Vella, and M. Croft. 1998. OX-40: life beyond the effector T cell stage. Semin. Immunol. 10:471-180.
17. Brugnoni, D., P. Airo, R. Marino, L.D. Notarangelo, R.A. van Lier, and R. Attaneo. 1997. CD70 expression on T-cell subpopulations: study of normal individuals and patients with chronic immune activation. Immunol. Lett. 55:99-104.
18. Mackay, F., J.L. Browning, P. Lawton, S.A. Shah, M. Comiskey, A.K. Bhan, E. Mizoguchi, C. Terhorst, and S.J. Simpson. 1998. Both lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis. Gastroenterology. 115:1464-1475.
19. Banchereau, J., F. Bazan, D. Blanchard, F. Briere, J.P. Galizzi, C. van Kooten, Y.J. Liu, F. Rousset, and S. Saeland. 1994. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881-922.
20. van Kooten, C., and J. Banchereau. 1997. Function of CD40 on B cells, dendritic cells and other cells. Curr. Opin. Immunol. 9:330-337.
21. 1 mice with established nephritis: preservation of kidney function. J. Immunol. 160:2158-2165.
22. Vogel, L.A., and R.J. Noelle. 1998. CD40 and its crucial role as a member of the TNFR family. Semin. Immunol. 10:435-442.
23. Schneider, P., F. Mackay, V. Steiner, K. Hofmann, J.L. Bodmer, N. Holler, C. Ambrose, P. Lawton, S. Bixler, H. Acha-Orbea, et al. 1999. BAFF, a novel ligand of the tumor necrosis factor (TNF) family, stimulates B-cell growth. J. Exp. Med. 189:1747-1756.
24. Shu, H.-B., W.-H. Hu, and H. Johnson. 1999. TALL-1 is a novel member of the TNF family that is down-regulated by mitogens.J. Leukoc. Biol. 65:680-683.
25. 2-terminal kinase. J. Biol. Chem. 274:15978-15981.
26. Moore, P.A., O. Belvedere, A. Orr, K. Pieri, D.W. LaFleur, P. Feng, D. Soppet, M. Charters, R. Gentz, D. Parmelee, et al. 1999. BlyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science. 285:260-263.
27. Mcknights, G.S., R.E. Hammer, E.A. Kuenzel, and R.L. Brinster. 1983. Expression of chicken transferrin gene in transgenic mice. Cell. 34:335-341.
28. Browning, J.L., I. Dougas Sizing, P. Lawton, P.R. Bourdon, P.D. Rennert, J.R. Majeau, C.M. Ambrose, C. Hession, K. Miatkowski, D.A. Griffith, et al. 1997. Characterization of lymphotoxin-αβ complexes on the surface of mouse lymphocytes. J. Immunol. 159:3288-3298.
29. Singh, V.K., and A.J. Tingle. 1982. Detection of circulating immune complexes by a C1q-microplate ELISA system. J. Immunol. Methods. 50:109-114.
30. June, C.H., C.E. Contreras, L.H. Perrin, and P.H. Lambert. 1979. Improved detection of immune complexes in human and mouse serum using a microassay adaptation of the C1q binding test. J. Immunol. Methods. 31:23-29.
31. Datta, S.K., H. Patel, and D. Berry. 1987. Induction of a cationic shift in IgG anti-DNA autoantibodies: role of helper T cells with classical and novel phenotypes in three murine models of lupus nephritis. J. Exp. Med. 165:1252-1261.
32. Mackay, F., G.R. Majeau, P. Lawton, P.S. Hochman, and J.L. Browning. 1997. Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice. Eur. J. Immunol. 27:2033-2042.
33. Oliver, A.M., F. Martin, G.L. Gartland, R.H. Carter, and J.F. Kearney. 1997. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory molecules. Eur. J. Immunol. 27:2366-2374.
34. Jefferis, R. 1995. Rheumatoid factors, B cells and immunoglobulin genes. Br. Med. Bull 51:312-331.
35. Chicheportiche, Y., P.R. Bourdon, H. Xu, Y.M. Hsu, H. Scott, C. Hession, I. Garcia, and J.L. Browning. 1997. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J. Biol. Chem. 272: 32401-32410.
36. Hahne, M., T. Kataoka, M. Schroter, K. Hofmann, M. Irmler, J.L. Bodmer, P. Schneider, T. Bornand, N. Holler, L. French, et al. 1998. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor growth. J. Exp. Med. 188:1185-1190.
37. Clegg, C.H., J.T. Rulffes, H.S. Haugen, I.H. Hoggatt, A. Aruffo, S.K. Durham, A.G. Farr, and D. Hollenbaugh. 1996. Thymus dysfunction and chronic inflammatory disease in gp39 transgenic mice. Int. Immunol 9:1111-1122.
38. Hollander, G.A., S.J. Simpson, E. Mizoguchi, A. Nichogiannopoulou, S. She, J.-C. Gutierrez-Ramos, A. Bhan, S.J. Burakoff, B. Wang, and C. Terhorst. 1995. Severe colitis resulting from aberrant thymic selection. Immunity. 3:27-38.
39. Kraal, G. 1992. Cells in the marginal zone of the spleen. Int. Rev. Cytol. 132:31-74.
40. Liu, Y.J., S. Oldfield, and I.C. MacLennan. 1988. Memory B cells in T cell-dependent antibody responses colonize the splenic marginal zones. Eur. J. Immunol. 18:355-362.
41. L escape negative selection and are tolerized by clonal anergy and receptor editing. Immunity. 9:35-45.
42. Chan, O.T.M., L.G. Hannum, A.M. Haberman, M.P. Madaio, and M.J. Schlomchik. 1999. A novel mouse with B cells lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 189:1639-1647.
43. Chao, D.T., and S.J. Korsmeyer. 1998. BCL-2 family: regulators of cell death. Annu. Rev. Immunol. 16:395-419.
44. Banchereau, J., and R.M. Steinman. 1998, Dendritic cells and the control of immunity. Nature. 392:245-252.